期刊文献+

^(99)锝~m-tetrofos min乳腺扫描鉴别乳腺包块性质的临床研究

A Clinical Study about ^(99)Tc^m-Tetrofosmin Imaging in Detection of Suspicious Palpable Breast Lesions
下载PDF
导出
摘要 目的探讨99锝m-tetrofosmin乳腺扫描在鉴别可扪及的乳腺包块良恶性质方面的价值。方法2000年6月至2002年1月在我院临床发现乳腺包块的104例患者接受了99锝m-tetrofosmin乳腺扫描。检查时先经病变对侧肘静脉注射740 MBq显像剂,注射后5、10及20 min分别采集前位和侧位图像。距阵256×256,每帧记数1~1.5 M,将99锝m-tetrofosmin在乳房局部浓聚视为亲肿瘤显像阳性。全部病例以术后病理结果为金标准,以四格表进行评价分析。结果99锝m-tetrofosmin在对可扪及的乳腺包块性质进行鉴别诊断时,特异性为84%,敏感性为87%,准确性为86%,阳性预测值为85%,阴性预测值为86%。结论99锝m-tetrofosmin在对可扪及的乳腺包块进行良恶性质的鉴别时,不失为一种较为准确的方法。 Objective To assess the value of ^99Tc^m-Tetrofosmin imaging in discriminating malignant mass from benign breast mass. Methods From June 2000 to January 2002, 104 patients with breast mass detected by clinical examination were included. After 740 MBq ^99Tc^m-Tetrofosmin was injected intravenously in the contralateral arm to the breast lesion, the front and the lateral images were collected in 5 min, 10 rain and 20 min respectively. ^99Tc^m-Tetrofosmin imaging localized in breast was defined as the positive sign of affinitive tumor. All patients underwent operation within one week. Using histological assessment as a golden standard, the sensitivity, specificity, positive and negative predictive value for ^99Tc^m-Tetrofosmin SPECT of the breast were calculated respectively. Resuits The sensitivity of ^99Tc^m-Tetrofosmin imaging for discriminating between malignant mass and benign mass in palpable breast lesions was 87 %, specificity 84 %, positive and negative predictive value were 85 % and 86 % respectively. Conclusion The results suggested that ^99Tc^m-Tetrofosmin imaging is a valuable tool for distinguishing between malignant mass and benign mass in palpable breast lesions.
出处 《中国普外基础与临床杂志》 CAS 2005年第6期609-611,共3页 Chinese Journal of Bases and Clinics In General Surgery
基金 四川省卫生厅科研基金资助项目(编号2000-000086)
关键词 乳腺包块 放射性核素显像 诊断 Breast mass Radionuclide imaging Diagnosis
  • 相关文献

参考文献9

  • 1Kerlikowske K, Grady D, Barclay J, et al. Effect of age, breast density, and family history on the sensitivity of first screening mammography [J]. JAMA, 1996; 276(1): 33
  • 2Taillefer R. The role of ^99Tcm-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis [J]. Semin Nucl Med, 1999; 29(1): 16
  • 3章斌.^(99)Tc^m-tetrofosmin在乳腺癌及其转移灶显像中的应用[J].国外医学(放射医学核医学分册),2001,25(1):12-15. 被引量:6
  • 4de Jong M, Bernard BF, Breeman WA, et al. Comparison of uptake of 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 into human breast cancer cell lines [J]. Eur J Nucl Med, 1996; 23(10): 1361
  • 5唐谨.核素乳腺显像的现状和今后工作的思考[J].中华核医学杂志,1997,17(2):69-70. 被引量:13
  • 6Mansi L, Rambaldi PF, Cuccurullo V, et al. Diagnostic and prognostic role of 99mTc-tetrofosmin in breast cancer [J]. Q J Nucl Med, 1997; 41(3): 239
  • 7Mansi L, Rambaldi PF, Procaccini E, et al. Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases [J]. Eur J Nucl Med, 1996; 23(8): 932
  • 8宋文忠,周蕾蕾,陈明曦,谢红军,黄劲,刘锦平,罗诚.^(99)Tc^m-Tetrofosmin显像对乳腺癌及腋窝淋巴结转移诊断价值评价[J].中国医学影像技术,2003,19(11):1531-1533. 被引量:7
  • 9Obwegeser R, Berghammer P, Muellauer-Ertl S, et al. 99m-Tc-tetrofosmin scintigraphy for the evaluation of suspicious palpable and non-palpable breast lesions [J]. Breast Cancer Res Treat, 2000; 62(3): 253

二级参考文献30

  • 1杜勇,中华核医学杂志,1997年,17卷,43页
  • 2岳明纲,中华核医学杂志,1996年,16卷,238页
  • 3徐玉秀,中华核医学杂志,1995年,15卷,230页
  • 4谷铣之,现代肿瘤学,1993年,460页
  • 5Rambaldi PF, Mansi L, Procaini E, et al. Breast cancer detestion with 99Tcm-tetrofosmin [J]. Clin Nucl Med, 1995,20:703-705.
  • 6Mansi L, Rambaldi PF, C uccurullo V, et al. Diagnostic and prognostic role of 99Tcm-tetrofosmin in breast cancer[J]. Q J Nucl Med, 1997,41:239-250.
  • 7Arbab AS, Koizumi K, Toyama K, et al. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines[J]. J Nucl Med,1996,37: 1551-1556.
  • 8De Jong M, Bernard BF,Breeman WAP, et al. Comparison of uptake of 99Tcm- MIBI, 99Tcm-tetrofosmin and 99Tcm-Q12 into human breast cancer cell lines[J].Eur J Nucl Med, 1996,23:1361-1366.
  • 9Ballinger JR, Bannerman J, Boxen I, et al. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrugresistant breast tumorcells[J]. J NuclMed, 1996, 37:1578-1582.
  • 10Higley B, Smith FW, Smith T, et al.Technetium99m- 1,2 -bis [bis ( 2-ethoxyethyl ) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent [J]. J Nucl Med,1993,34:30-38.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部